Ying Du
Net worth: 18 M $ as of 31/05/2026
Net worth: 18 M $ as of 31/05/2026
Founder of Zai Lab Ltd., Hutchison MediPharma Ltd. and Zai Venture Partners, Ying Du is an entrepreneur who occupies the position of Chairman & Chief Executive Officer at Zai Lab Ltd. and General Partner at Zai Venture Partners (a subsidiary of Zai Lab Ltd.). Dr. Du is also on the board of Eden Biologics, Inc. In the past Dr. Du occupied the position of Chief Executive Officer for Hutchison MediPharma Ltd., Chief Scientific Officer at Hutchison China MediTech Ltd., Executive Vice President-Healthcare Investment at Hutchison Whampoa (China) Ltd. and Venture Partner at Sequoia Capital China Advisors (Hong Kong) Ltd. Ying Du received a doctorate from the University of Cincinnati (Ohio) and an undergraduate degree from Jilin University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ZAI LAB LTD. 0.89% | 27/05/2026 | 10,102,671 ( 0.89% ) | 18 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ZAI LAB LIMITED | Chief Executive Officer | 01/04/2014 |
| JHL BIOTECH, INC. | Director/Board Member | 17/12/2012 |
Zai Venture Partners
Zai Venture Partners Investment ManagersFinance Zai Venture Partner seeks investment opportunities in companies located in China. The firm target companies operating in the fields of biotechnology and pharmaceutical business sector. It provides financing for early stage transactions. | Founder | 01/01/2017 |
| Companies | Position | End |
|---|---|---|
Wuhan HongShan Huanxia Technology Co., Ltd.
Wuhan HongShan Huanxia Technology Co., Ltd. Investment ManagersFinance Wuhan HongShan Huanxia Technologyh invests in companies located across the globe. The firm focuses on technology, healthcare and consumer sectors. It provides financing for seed, early, growth, buyout, infrastructure and public equities stage capital requirements. | Private Equity Investor | - |
Hutchison Whampoa (China) Ltd.
Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | - |
| HUTCHMED (CHINA) LIMITED | Chief Tech/Sci/R&D Officer | - |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Discovers and develops innovative human therapeutics | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
HUTCHMED (China) Ltd.
HUTCHMED (China) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products | Health Technology |
Hutchison Whampoa (China) Ltd.
Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
University of Cincinnati (Ohio)
University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jilin University
Jilin University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wuhan HongShan Huanxia Technology Co., Ltd.
Wuhan HongShan Huanxia Technology Co., Ltd. Investment ManagersFinance Wuhan HongShan Huanxia Technologyh invests in companies located across the globe. The firm focuses on technology, healthcare and consumer sectors. It provides financing for seed, early, growth, buyout, infrastructure and public equities stage capital requirements. | Finance |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Discovers and develops innovative human therapeutics | Health Technology |
Eden Biologics, Inc.
Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Zai Venture Partners
Zai Venture Partners Investment ManagersFinance Zai Venture Partner seeks investment opportunities in companies located in China. The firm target companies operating in the fields of biotechnology and pharmaceutical business sector. It provides financing for early stage transactions. | Finance |
Select your edition
All financial news and data tailored to specific country editions